相似文献
1
Coordinated tumor immunity.
J Clin Invest. 2003 Apr;111(8):1116-8. doi: 10.1172/JCI18359.
2
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas.
J Clin Invest. 2003 Apr;111(8):1161-70. doi: 10.1172/JCI17426.
3
Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag.
Cytotherapy. 2007;9(1):23-34. doi: 10.1080/14653240601048369.
4
Cancer immunoprevention.
Future Oncol. 2005 Feb;1(1):57-66. doi: 10.1517/14796694.1.1.57.
5
Co-expression of Flt-3 ligand gene ablates tumor immunity elicited by HER-2/neu DNA vaccine in transgenic mice.
Vaccine. 2010 May 14;28(22):3841-7. doi: 10.1016/j.vaccine.2010.03.010. Epub 2010 Mar 29.
6
7
Enhanced efficacy of DNA vaccination against Her-2/neu tumor antigen by genetic adjuvants.
Int J Cancer. 2004 Aug 10;111(1):86-95. doi: 10.1002/ijc.20232.
8
Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice.
Cell Immunol. 2006 Apr;240(2):96-106. doi: 10.1016/j.cellimm.2006.07.002. Epub 2006 Aug 22.
9
HER-2/neu as a target for cancer vaccines.
Immunotherapy. 2010 Mar;2(2):213-26. doi: 10.2217/imt.09.89.
10
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins.
Cancer Res. 2010 Apr 1;70(7):2604-12. doi: 10.1158/0008-5472.CAN-09-2548. Epub 2010 Mar 23.
引用本文的文献
1
WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
Cancer Med. 2021 Jun;10(12):4004-4016. doi: 10.1002/cam4.3946. Epub 2021 May 12.
2
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells.
Oncoimmunology. 2018 Oct 11;8(1):e1505174. doi: 10.1080/2162402X.2018.1505174. eCollection 2019.
3
Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: role of uric acid accumulation in gemcitabine-induced MICA/B expression.
BMC Cancer. 2011 May 23;11:194. doi: 10.1186/1471-2407-11-194.
4
The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells.
Ann N Y Acad Sci. 2009 Sep;1174:6-17. doi: 10.1111/j.1749-6632.2009.04933.x.
5
Elevation of inducible nitric oxide synthase and cyclooxygenase-2 expression in the mouse brain after chronic nonylphenol exposure.
Int J Mol Sci. 2008 Oct;9(10):1977-88. doi: 10.3390/ijms9101977. Epub 2008 Oct 24.
6
The paradox of T-cell-mediated antitumor immunity in spite of poor clinical outcome in human melanoma.
Cancer Immunol Immunother. 2004 Oct;53(10):855-64. doi: 10.1007/s00262-004-0526-8. Epub 2004 Jun 3.
7
Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.
Clin Exp Immunol. 2003 Nov;134(2):169-77. doi: 10.1046/j.1365-2249.2003.02259.x.
本文引用的文献
1
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas.
J Clin Invest. 2003 Apr;111(8):1161-70. doi: 10.1172/JCI17426.
2
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.
N Engl J Med. 2003 Jan 16;348(3):203-13. doi: 10.1056/NEJMoa020177.
3
Inflammation and cancer.
Nature. 2002;420(6917):860-7. doi: 10.1038/nature01322.
4
The innate immune response to tumors and its role in the induction of T-cell immunity.
Immunol Rev. 2002 Oct;188:9-21. doi: 10.1034/j.1600-065x.2002.18802.x.
5
A controlled trial of a human papillomavirus type 16 vaccine.
N Engl J Med. 2002 Nov 21;347(21):1645-51. doi: 10.1056/NEJMoa020586.
6
Cancer immunoediting: from immunosurveillance to tumor escape.
Nat Immunol. 2002 Nov;3(11):991-8. doi: 10.1038/ni1102-991.
7
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice.
J Exp Med. 2001 Nov 5;194(9):1195-205. doi: 10.1084/jem.194.9.1195.
8
DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.
J Immunol. 2000 Nov 1;165(9):5133-42. doi: 10.4049/jimmunol.165.9.5133.
9
The hallmarks of cancer.
Cell. 2000 Jan 7;100(1):57-70. doi: 10.1016/s0092-8674(00)81683-9.
10
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.
J Clin Oncol. 1998 Aug;16(8):2659-71. doi: 10.1200/JCO.1998.16.8.2659.
Zotero 插件